Cuvposa is a prescription drug approved by the Food and Drug Administration (FDA) to treat chronic severe drooling in people ages 3 to 16 with neurological conditions. Cuvposa may be prescribed off-label to treat certain types of excessive sweating in children who have not found relief from other treatments. Cuvposa may be used on an as-needed basis to temporarily stop sweating during special events. Cuvposa is also known by its drug name, Glycopyrrolate.
Cuvposa is an anticholinergic. Cuvposa is believed to work by blocking chemical messengers that trigger the sweat glands to produce sweat.
How do I take it?
Take Cuvposa as prescribed by your doctor.
Cuvposa comes in oral solution form.
The FDA-approved label for Cuvposa lists common side effects including dry mouth, nasal congestion, flushing, and constipation.
Rare but serious side effects listed for Cuvposa include intestinal obstruction and increased risk for heat prostration (fever and heatstroke).
For more details about this treatment, visit:
Cuvposa – Merz Pharmaceuticals
Medications – International Hyperhidrosis Society
We never share your personal information with anyone.